Lasix for the prevention of de novo postpartum hypertension: a randomized placebo-controlled trial (LAPP Trial)
Open Access
- 18 April 2024
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 232 (1) , 125.e1-125.e21
Abstract
No abstract availableKeywords
Funding Information
- Irving Medical Center, Columbia University
This publication has 26 references indexed in Scilit:
- Toward the elimination of race-based medicine: replace race with racism as preeclampsia risk factorAmerican Journal of Obstetrics and Gynecology, 2022
- Incidence of and risk factors for de novo postpartum hypertensionAmerican Journal of Obstetrics and Gynecology, 2022
- Maternal mortality in the United States: research gaps, opportunities, and prioritiesAmerican Journal of Obstetrics and Gynecology, 2020
- LB 4: Furosemide for Accelerated Recovery of Blood Pressure Postpartum: a randomized placebo controlled trial (FoR BP)American Journal of Obstetrics and Gynecology, 2020
- Prevalence, risk factors and associated complications of postpartum hypertension in rural HaitiPregnancy Hypertension, 2017
- Blood pressure changes during the first stage of labor and for the prediction of early postpartum preeclampsia: a prospective studyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2015
- Risk factors for new-onset late postpartum preeclampsia in women without a history of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2014
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Maternal death in the 21st century: causes, prevention, and relationship to cesarean deliveryAmerican Journal of Obstetrics and Gynecology, 2008
- Delayed postpartum preeclampsia: an experience of 151 casesAmerican Journal of Obstetrics and Gynecology, 2004